SPIC's pharmaceuticals portfolio includes: - Fermentation-based Penicillin-G—among the world's most cost-effective; - Customs synthesis and contract manufacturing of active pharmaceutical ingredients (apsis), drug intermediates, and synthetic organics compounds for global innovator companies; - Finished dosage forms; - Plant-based neutraceuticals. An advanced research center and internationally accredited manufacturing facilities together support SPIC in ensuring that its products conform to the highest standards of quality, safety and efficacy.